ATE462746T1 - Blockcopolymer mit verringertem verunreinigungsgehalt, polymerer träger, pharmazeutische zubereitungen in polymerer form und verfahren zur herstellung davon - Google Patents
Blockcopolymer mit verringertem verunreinigungsgehalt, polymerer träger, pharmazeutische zubereitungen in polymerer form und verfahren zur herstellung davonInfo
- Publication number
- ATE462746T1 ATE462746T1 AT02743647T AT02743647T ATE462746T1 AT E462746 T1 ATE462746 T1 AT E462746T1 AT 02743647 T AT02743647 T AT 02743647T AT 02743647 T AT02743647 T AT 02743647T AT E462746 T1 ATE462746 T1 AT E462746T1
- Authority
- AT
- Austria
- Prior art keywords
- block copolymer
- polymeric
- carrier
- production
- pharmaceutical preparations
- Prior art date
Links
- 229920001400 block copolymer Polymers 0.000 title abstract 2
- 239000012535 impurity Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 abstract 3
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 230000001351 cycling effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 150000002334 glycols Chemical class 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Polyamides (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Materials For Medical Uses (AREA)
- Polyethers (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001187175 | 2001-06-20 | ||
| JP2001187176 | 2001-06-20 | ||
| PCT/JP2002/006112 WO2003000771A1 (fr) | 2001-06-20 | 2002-06-19 | Copolymere bloc a taux d'impuretes reduit, support polymere, preparations pharmaceutiques sous forme polymere et procede de preparation associe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE462746T1 true ATE462746T1 (de) | 2010-04-15 |
Family
ID=26617300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02743647T ATE462746T1 (de) | 2001-06-20 | 2002-06-19 | Blockcopolymer mit verringertem verunreinigungsgehalt, polymerer träger, pharmazeutische zubereitungen in polymerer form und verfahren zur herstellung davon |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7138490B2 (de) |
| EP (1) | EP1408066B1 (de) |
| JP (1) | JP4462928B2 (de) |
| KR (1) | KR100924990B1 (de) |
| CN (1) | CN100378140C (de) |
| AT (1) | ATE462746T1 (de) |
| AU (1) | AU2002346296B2 (de) |
| CA (1) | CA2450448C (de) |
| DE (1) | DE60235812D1 (de) |
| ES (1) | ES2343679T3 (de) |
| PL (1) | PL222061B1 (de) |
| RU (1) | RU2282641C2 (de) |
| WO (1) | WO2003000771A1 (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003280592B2 (en) * | 2002-10-31 | 2008-12-18 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight derivatives of camptothecins |
| JP4535229B2 (ja) * | 2003-05-08 | 2010-09-01 | 国立大学法人 東京大学 | ポリエチレングリコール−ポリカチオンブロック共重合体 |
| WO2004105799A1 (ja) * | 2003-05-29 | 2004-12-09 | Toudai Tlo, Ltd. | 安定化高分子ミセル |
| KR100977697B1 (ko) * | 2003-10-10 | 2010-08-24 | 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 | 탄소 화합물이 봉입된 미소 입자의 복합체 |
| JP4820758B2 (ja) * | 2004-09-22 | 2011-11-24 | 日本化薬株式会社 | 新規ブロック共重合体、ミセル調製物及びそれを有効成分とする抗癌剤 |
| JPWO2007034795A1 (ja) * | 2005-09-20 | 2009-03-26 | 株式会社ジェノラックＢｌ | γ−ポリグルタミン酸架橋物及びその製造方法 |
| KR20080064827A (ko) | 2005-10-05 | 2008-07-09 | 도쿄 씨알오 가부시키가이샤 | 생체 적합성 블록 공중합체, 그 용도 및 제조법 |
| CA2631704A1 (en) | 2005-12-05 | 2007-06-14 | Nitto Denko Corporation | Polyglutamate-amino acid conjugates and methods |
| US8323669B2 (en) | 2006-03-28 | 2012-12-04 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of taxane |
| RU2447095C2 (ru) | 2006-05-18 | 2012-04-10 | Ниппон Каяку Кабусики Кайся | Высокомолекулярный конъюгат подофиллотоксинов |
| JP5548364B2 (ja) * | 2006-10-03 | 2014-07-16 | 日本化薬株式会社 | レゾルシノール誘導体の高分子結合体 |
| US8334364B2 (en) | 2006-11-06 | 2012-12-18 | Nipon Kayaku Kabushiki Kaisha | High-molecular weight derivative of nucleic acid antimetabolite |
| JP5548365B2 (ja) | 2006-11-08 | 2014-07-16 | 日本化薬株式会社 | 核酸系代謝拮抗剤の高分子誘導体 |
| US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
| CN101674852A (zh) * | 2007-04-10 | 2010-03-17 | 日东电工株式会社 | 多功能聚谷氨酸盐药物载体 |
| CA2683590A1 (en) * | 2007-05-09 | 2008-11-20 | Nitto Denko Corporation | Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| CN101707869A (zh) * | 2007-05-09 | 2010-05-12 | 日东电工株式会社 | 具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物 |
| JP2010528122A (ja) * | 2007-05-09 | 2010-08-19 | 日東電工株式会社 | 白金薬剤と結合されたポリマー |
| KR100941774B1 (ko) * | 2007-09-06 | 2010-02-11 | 성균관대학교산학협력단 | 인체안전성이 우수한 온도 및 피에치 민감성 블록공중합체및 이의 제조방법과 이를 이용한 약물전달체 |
| JP5349318B2 (ja) | 2007-09-28 | 2013-11-20 | 日本化薬株式会社 | ステロイド類の高分子結合体 |
| CN101910246B (zh) * | 2007-12-31 | 2013-01-02 | 株式会社三养生物制药 | 包含源自α-羟酸的疏水嵌段的高纯两亲共聚物及其制备方法 |
| WO2009111271A1 (en) * | 2008-03-06 | 2009-09-11 | Nitto Denko Corporation | Polymer paclitaxel conjugates and methods for treating cancer |
| CN101977631A (zh) | 2008-03-18 | 2011-02-16 | 日本化药株式会社 | 生理活性物质的高分子量偶联物 |
| ES2449865T5 (es) | 2008-04-16 | 2022-11-18 | Momenta Pharmaceuticals Inc | Análisis de composiciones de copolímeros de aminoácidos |
| JP5366940B2 (ja) | 2008-05-08 | 2013-12-11 | 日本化薬株式会社 | 葉酸若しくは葉酸誘導体の高分子結合体 |
| JP5037684B2 (ja) * | 2008-05-23 | 2012-10-03 | ナノキャリア株式会社 | ドセタキセル高分子誘導体、並びにその製造方法及びその用途 |
| JP5544357B2 (ja) | 2009-05-15 | 2014-07-09 | 日本化薬株式会社 | 水酸基を有する生理活性物質の高分子結合体 |
| KR20140024833A (ko) | 2010-11-17 | 2014-03-03 | 니폰 가야꾸 가부시끼가이샤 | 신규한 시티딘계 대사길항제의 고분자 유도체 |
| WO2013009885A2 (en) | 2011-07-11 | 2013-01-17 | Momenta Pharmaceuticals, Inc. | Evaluation of copolymer diethylamide |
| US8575198B1 (en) | 2011-09-07 | 2013-11-05 | Momenta Pharmaceuticals, Inc. | In-process control for the manufacture of glatiramer acetate |
| CN103874722B (zh) | 2011-09-11 | 2016-06-29 | 日本化药株式会社 | 嵌段共聚物的制造方法 |
| US8691925B2 (en) | 2011-09-23 | 2014-04-08 | Az Electronic Materials (Luxembourg) S.A.R.L. | Compositions of neutral layer for directed self assembly block copolymers and processes thereof |
| US8686109B2 (en) * | 2012-03-09 | 2014-04-01 | Az Electronic Materials (Luxembourg) S.A.R.L. | Methods and materials for removing metals in block copolymers |
| US10457088B2 (en) | 2013-05-13 | 2019-10-29 | Ridgefield Acquisition | Template for self assembly and method of making a self assembled pattern |
| US9093263B2 (en) | 2013-09-27 | 2015-07-28 | Az Electronic Materials (Luxembourg) S.A.R.L. | Underlayer composition for promoting self assembly and method of making and using |
| KR20150066151A (ko) | 2013-12-06 | 2015-06-16 | 삼성전자주식회사 | 블록 공중합체의 정제 방법 및 블록 공중합체를 이용한 패턴 형성 방법 |
| US9181449B2 (en) | 2013-12-16 | 2015-11-10 | Az Electronic Materials (Luxembourg) S.A.R.L. | Underlayer composition for promoting self assembly and method of making and using |
| CN104109235B (zh) * | 2014-05-30 | 2017-07-18 | 厦门赛诺邦格生物科技股份有限公司 | 一种具有氮原子支化中心的单一官能化聚乙二醇、制备方法及其生物相关物质 |
| KR101726728B1 (ko) * | 2015-07-28 | 2017-04-14 | 주식회사 삼양바이오팜 | 고분자 담체 함유 약학 조성물의 유연물질 분석 방법 |
| EP3400945A4 (de) | 2016-01-08 | 2019-09-11 | Nippon Kayaku Kabushiki Kaisha | Polymerderivat von macrolid-immunosuppressiva |
| SG11201900207PA (en) | 2016-08-18 | 2019-03-28 | Az Electronic Mat Luxembourg Sarl | Polymer compositions for self-assembly applications |
| EP3858872B1 (de) | 2016-12-21 | 2022-05-11 | Merck Patent GmbH | Zusammensetzungen und verfahren zur selbstassemblierung von blockcopolymeren |
| CN107313258A (zh) * | 2017-06-23 | 2017-11-03 | 安徽金钻智能科技有限公司 | 一种蚕丝织物精炼用低泡耐碱渗透剂 |
| SG11202103809PA (en) | 2018-12-07 | 2021-05-28 | Merck Patent Gmbh | Rapid cross-linkable neutral underlayers for contact hole self-assembly of polystyrene-b- poly(methyl methacrylate) diblock copolymers and their formulation thereof |
| CA3250008A1 (en) * | 2022-03-17 | 2025-03-04 | Nof Corporation | PROCESS FOR PRODUCING A POLYETHYLENE GLYCOL DERIVATIVE |
| CN115894905B (zh) * | 2022-08-30 | 2023-08-08 | 山东华铂凯盛生物科技有限公司 | 一种高纯度窄分子量分布的甲氧基聚乙二醇-聚（l-谷氨酸钠）的制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2517760B2 (ja) * | 1989-05-11 | 1996-07-24 | 新技術事業団 | 水溶性高分子化医薬製剤 |
| AU636481B2 (en) * | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| JP3111099B2 (ja) * | 1991-10-31 | 2000-11-20 | 科学技術振興事業団 | 水溶性高分子化薬剤の製造法 |
| JP3270592B2 (ja) | 1992-10-26 | 2002-04-02 | 日本化薬株式会社 | ブロック共重合体−抗癌剤複合体医薬製剤 |
| JP3268913B2 (ja) | 1992-10-27 | 2002-03-25 | 日本化薬株式会社 | 高分子担体 |
| JP3682475B2 (ja) | 1993-08-31 | 2005-08-10 | 靖久 桜井 | 水溶性抗癌剤 |
| DE69625326T2 (de) * | 1995-09-29 | 2003-09-18 | Japan Science And Technology Corp., Kawaguchi | Anthracyclinderivate und sie enthaldende medizinische zubereitungen |
-
2002
- 2002-06-19 EP EP02743647A patent/EP1408066B1/de not_active Expired - Lifetime
- 2002-06-19 PL PL366773A patent/PL222061B1/pl unknown
- 2002-06-19 DE DE60235812T patent/DE60235812D1/de not_active Expired - Lifetime
- 2002-06-19 KR KR1020037016687A patent/KR100924990B1/ko not_active Expired - Lifetime
- 2002-06-19 RU RU2004101281/04A patent/RU2282641C2/ru active
- 2002-06-19 JP JP2003507171A patent/JP4462928B2/ja not_active Expired - Lifetime
- 2002-06-19 AU AU2002346296A patent/AU2002346296B2/en not_active Expired
- 2002-06-19 US US10/481,347 patent/US7138490B2/en not_active Expired - Lifetime
- 2002-06-19 ES ES02743647T patent/ES2343679T3/es not_active Expired - Lifetime
- 2002-06-19 CN CNB028122844A patent/CN100378140C/zh not_active Expired - Lifetime
- 2002-06-19 WO PCT/JP2002/006112 patent/WO2003000771A1/ja not_active Ceased
- 2002-06-19 CA CA2450448A patent/CA2450448C/en not_active Expired - Lifetime
- 2002-06-19 AT AT02743647T patent/ATE462746T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL222061B1 (pl) | 2016-06-30 |
| JPWO2003000771A1 (ja) | 2004-10-07 |
| RU2282641C2 (ru) | 2006-08-27 |
| EP1408066A4 (de) | 2004-09-29 |
| PL366773A1 (en) | 2005-02-07 |
| AU2002346296B2 (en) | 2007-09-13 |
| CA2450448A1 (en) | 2003-01-03 |
| JP4462928B2 (ja) | 2010-05-12 |
| ES2343679T3 (es) | 2010-08-06 |
| CN100378140C (zh) | 2008-04-02 |
| DE60235812D1 (de) | 2010-05-12 |
| CA2450448C (en) | 2011-12-13 |
| KR20040030693A (ko) | 2004-04-09 |
| CN1518573A (zh) | 2004-08-04 |
| EP1408066B1 (de) | 2010-03-31 |
| EP1408066A1 (de) | 2004-04-14 |
| WO2003000771A1 (fr) | 2003-01-03 |
| RU2004101281A (ru) | 2005-06-27 |
| KR100924990B1 (ko) | 2009-11-04 |
| US7138490B2 (en) | 2006-11-21 |
| US20040151690A1 (en) | 2004-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE462746T1 (de) | Blockcopolymer mit verringertem verunreinigungsgehalt, polymerer träger, pharmazeutische zubereitungen in polymerer form und verfahren zur herstellung davon | |
| WO2002058638A3 (en) | Serpin drugs for treatment of hiv infection and method of use thereof | |
| CA2327187A1 (en) | Transdermal therapeutic system containing pergolide | |
| BR9610838A (pt) | Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização. | |
| EP1133989A3 (de) | Polymer zur therapeutischen Anwendung | |
| BR0207760A (pt) | Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição | |
| EP0958356A4 (de) | Verfahren zur herstellung einer verbindung durch polymerisierung einer modelldroge | |
| SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| EP1281722A4 (de) | Hyaluronsäuregel, verfahren zu dessen herstellung sowie das gel enthaltendes medizinisches material | |
| DE69417538D1 (de) | Maleinsäurecopolymer, verfahren zur herstellung und dessen anwendung | |
| DE60236814D1 (de) | 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung | |
| CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
| DE69023352D1 (de) | Verfahren zur Herstellung mikroporöser Folien aus Polyethylen von ultrahohem Molekulargewicht. | |
| IL126917A0 (en) | A method for treating viral infections and a pharmaceutical composition for treating the same | |
| WO2003032907A3 (en) | High-concentration protein formulations and method of manufacture | |
| WO2003070755A3 (fr) | Composes et compositions pour le transport de la cyclosporine a travers la barriere hemato-encephalique | |
| DE69428350D1 (en) | Polymere ionene als anthelminthika in tieren | |
| CA2300679A1 (en) | Method of reducing intestinal gas, cramping and anorectal irritation | |
| DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
| ATE175236T1 (de) | Antithrombin-polypeptide | |
| CA2591307A1 (en) | Injectable veterinary composition | |
| ATE237579T1 (de) | Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. | |
| WO2001068676A3 (de) | Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel | |
| ATE171620T1 (de) | Verwendung von verzweigtkettigen aminosäuren zur herstellung eines arzneimittels zur behandlung von tardiver dyskinesia | |
| WO2000032629A3 (en) | Antiviral peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |